Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma
This study has been completed.
Study NCT00338988 Information provided by M.D. Anderson Cancer Center
First Received: June 16, 2006 Last Updated: October 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer of the Gallbladder
Cancer of the Biliary Tract
Additional conditions recognized in this trial
Biliary Tract Neoplasms
Cholangiocarcinoma
Gallbladder Neoplasms
More general conditions related to this trial
Adenocarcinoma
Biliary Tract Diseases
Carcinoma
Digestive System Diseases
Digestive System Neoplasms
Gallbladder Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
Capecitabine
Oxaliplatin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Sanofi-Synthelabo
Back to top of Main Content
